Vascular Pharmacology

SJR Rank #4,979H-index: 114SJR: 0.990Best quartile: Q2APC: US$3,670
Journal website: aims, scope and author guidelines
Publisher

Elsevier Inc.

Country

United States

Type

journal

SJR by Edition

2022202500.250.50.751

Subject Categories

  • Molecular MedicineQ2
  • PharmacologyQ2
  • PhysiologyQ2

Areas: Biochemistry, Genetics and Molecular Biology · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Nitric Oxide and Endothelin EffectsDiverse Scientific and Economic StudiesHuman auditory perception and evaluationAngiogenesis and VEGF in CancerEducational Robotics and EngineeringAtherosclerosis and Cardiovascular DiseasesRenin-Angiotensin System StudiesEicosanoids and Hypertension PharmacologyPulmonary Hypertension Research and TreatmentsManufacturing Process and Optimization

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs055110165220

Documents per Year

20222025020406080

Detailed Information

ISSN

1879-3649, 1537-1891

SJR Best Quartile

Q2

Region

Northern America

Citations per Document (2 years)

3.23

References per Document

74.84

Coverage

2002-2026

Scope

Vascular Pharmacology publishes papers, which contains results of all aspects of biology and pharmacology of the vascular system. Papers are encouraged in basic, translational and clinical aspects of Vascular Biology and Pharmacology, utilizing approaches ranging from molecular biology to integrative physiology. All papers are in English. The Journal publishes review articles which include vascular aspects of thrombosis, inflammation, cell signalling, atherosclerosis, and lipid metabolism.

Metrics from SCImago Journal Rank 2025. View on SCImago